img

Post-pandemic Era Global Pemetrexed Market Segment Research Report 2024


Published on: 2024-01-04 | No of Pages : 212 | Industry : Medical Devices & Consumables Research Center

Publisher : XMR | Format : PDF

Post-pandemic Era Global Pemetrexed Market Segment Research Report 2024

Summary

The global economy is expected to expand 5.6% in 2021,global recovery is strong but uneven as many emerging market and developing economies continue to struggle with the COVID-19 pandemic, the world is unlikely to ever reach global herd immunity. However, the recovery in many countries is being held back by a resurgence of COVID-19 cases and lagging vaccination progress, as well as the withdrawal of policy support in some instances.

The annual U.S. economic growth rate slipped to -3.5% in 2020, but grew at a yearly pace of more than 6% in the previous two quarters of 2021. The economy of continental Europe bounced back in the second quarter after having contracted in both the fourth quarter of 2020 and the first quarter of 2021, as the vaccinations accelerated, and governments eased restrictions. Among major economies, the annualized growth rate was 6.1% in Germany, 3.6% in France, 11.2% in Italy, and 11.7% in Spain. The especially rapid growth in Spain and Italy was attributed to a surge in consumer spending, likely the result of an easing of economic restrictions.

Regional Economic ProspectsGrowth in the East Asia and Pacific is projected to accelerate by 7.7% in 2021, Central Asia is forecast to grow by 3.9% this year, economic activity in the Middle East and North Africa is forecast to advance by 2.4%, South Asia is projected to expand by 6.8%.

The global Pemetrexed market size was USD XX billion in 2021. It is likely to progress at a CAGR of XX% during the forecast period of 2022-2027, according to MR Accuracy Reports analysis, The segment in Pemetrexed market is estimated to reach a market value of USD XX billion by 2021 from an initial market value of USD XX billion in 2021. China market value in 2021 is about USD XX billion, and China Pemetrexed production is XX (K Units). US market value in 2021 is about USD XX billion, and US Pemetrexed production is XX (K Units). Europe market value in 2021 is about USD XX billion, and Europe Pemetrexed production is XX (K Units).

Regional Segmentation (Value; Revenue, USD Million, 2017 - 2027) of Pemetrexed Market by MR Accuracy Reports Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Pemetrexed Market?
Eli Lilly
Abbott Healthcare
Cadila Healthcare
...
...
Major Type of Pemetrexed Covered in MR Accuracy Reports report
100mg
500mg
Application Segments Covered in MR Accuracy Reports Market
Pleural Mesothelioma
Non-small Cell Lung Cancer

For any other requirements, please feel free to contact us and we will provide you customized report.

Table of Content

Table of Contents

Global Pemetrexed Market Segment Research Report 2021
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Pemetrexed Market by Value
2.2.1 Global Pemetrexed Revenue by Type
2.2.2 Global Pemetrexed Market by Value (%)
2.3 Global Pemetrexed Market by Production
2.3.1 Global Pemetrexed Production by Type
2.3.2 Global Pemetrexed Market by Production (%)

3. The Major Driver of Pemetrexed Industry
3.1 Historical & Forecast Global Pemetrexed Demand
3.2 Largest Application for Pemetrexed (2017-2027)
3.3 The Major Downstream Company in China Market 2021

4. Global and Regional Pemetrexed Market
4.1 Regional Market Size in Terms of Production & Demand (2021)
4.2 Regional Market Share in Terms of Revenue (2019-2027)
4.3 Concentration Ratio (CR5& CR10) of Pemetrexed Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US Pemetrexed Production, Demand (2017-2027)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Demand Breakdown by Type
5.3 Current and Estimated Demand Breakdown by Application
5.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
5.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

6. Europe Pemetrexed Production, Demand (2017-2027)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Demand Breakdown by Type
6.3 Current and Estimated Demand Breakdown by Application
6.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
6.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

7. China Pemetrexed Production, Demand (2017-2027)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Demand Breakdown by Type
7.3 Current and Estimated Demand Breakdown by Application
7.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
7.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

8. Japan Pemetrexed Production, Demand (2017-2027)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Demand Breakdown by Type
8.3 Current and Estimated Demand Breakdown by Application
8.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
8.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

9. India Pemetrexed Production, Demand (2017-2027)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Demand Breakdown by Type
9.3 Current and Estimated Demand Breakdown by Application
9.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
9.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

10. Korea Pemetrexed Production, Demand (2017-2027)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Demand Breakdown by Type
10.3 Current and Estimated Demand Breakdown by Application
10.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
10.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

11. Southeast Asia Pemetrexed Production, Demand (2017-2027)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Demand Breakdown by Type
11.3 Current and Estimated Demand Breakdown by Application
11.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
11.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

12. Global Pemetrexed Average Price Trend
12.1 Market Price for Each Type of Pemetrexed in US (2017-2021)
12.2 Market Price for Each Type of Pemetrexed in Europe (2017-2021)
12.3 Market Price for Each Type of Pemetrexed in China (2017-2021)
12.4 Market Price for Each Type of Pemetrexed in Japan (2017-2021)
12.5 Market Price for Each Type of Pemetrexed in India (2017-2021)
12.6 Market Price for Each Type of Pemetrexed in Korea (2017-2021)
12.7 Market Price for Each Type of Pemetrexed in Southeast Asia (2017-2021)

13. Industrial Chain (Impact of COVID-19)
13.1 Pemetrexed Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Technology Trends of Pemetrexed

14. Pemetrexed Competitive Landscape
14.1 Eli Lilly
14.1.1 Eli Lilly Company Profiles
14.1.2 Eli Lilly Product Introduction
14.1.3 Eli Lilly Pemetrexed Sales, Revenue (2017-2021)
14.1.4 Strategic initiatives
14.2 Abbott Healthcare
14.2.1 Abbott Healthcare Company Profiles
14.2.2 Abbott Healthcare Product Introduction
14.2.3 Abbott Healthcare Pemetrexed Sales, Revenue (2017-2021)
14.2.4 Strategic initiatives
14.3 Cadila Healthcare
14.3.1 Cadila Healthcare Company Profiles
14.3.2 Cadila Healthcare Product Introduction
14.3.3 Cadila Healthcare Pemetrexed Sales, Revenue (2017-2021)
14.3.4 Strategic initiatives
14.4 ...
14.4.1 ... Company Profiles
14.4.2 ... Product Introduction
14.4.3 ... Pemetrexed Sales, Revenue (2017-2021)
14.4.4 Strategic initiatives
15. Conclusion


List of Figure

List of Tables and Figures

Figure 1. Total Demand by Application of Pemetrexed Industry (Volume)
Figure 2. Pemetrexed Production & Demand by Regions in 2021
Figure 3. Regional Market Share in Terms of Revenue (2021&2027)
Figure 4. The Top 10 and 5 Players Market Share by Pemetrexed Revenue in 2021
Figure 5. US Pemetrexed Production, Demand (2017-2027)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Pemetrexed Production, Demand (2017-2027)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Pemetrexed Production, Demand (2017-2027)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Pemetrexed Production, Demand (2017-2027)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Pemetrexed Production, Demand (2017-2027)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Pemetrexed Production, Demand (2017-2027)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Pemetrexed Production, Demand (2017-2027)
Figure 43. Current and Estimated Production Breakdown by Type (2017-2027)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Pemetrexed Revenue, by Type (Million USD) (2017-2027)
Table 4. Pemetrexed Production, by Type (K Unit) (2017-2027)
Table 5. Pemetrexed Demand (K Unit) by Application (2017-2027)
Table 6. Pemetrexed Demand (Million USD) by Application (2017-2027)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2021)
Table 9. Regional Market Share in Terms of Revenue (2021&2027)
Table 10. Ranking of Global Top Pemetrexed Companies by Revenue, Concentration Ratio in 2021
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Pemetrexed Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 13. Current and Estimated Production Breakdown by Type (2017-2027)
Table 14. Current and Estimated Demand Breakdown by Type (2017-2027)
Table 15. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Pemetrexed Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 19. Current and Estimated Production Breakdown by Type (2017-2027)
Table 20. Current and Estimated Demand Breakdown by Type (2017-2027)
Table 21. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Pemetrexed Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Pemetrexed Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 30. Current and Estimated Production Breakdown by Type (2017-2027)
Table 31. Current and Estimated Demand Breakdown by Type (2017-2027)
Table 32. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Pemetrexed Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 36. Current and Estimated Production Breakdown by Type (2017-2027)
Table 37. Current and Estimated Demand Breakdown by Type (2017-2027)
Table 38. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Pemetrexed Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 42. Current and Estimated Production Breakdown by Type (2017-2027)
Table 43. Current and Estimated Demand Breakdown by Type (2017-2027)
Table 44. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Pemetrexed Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 48. Table Current and Estimated Demand Breakdown by Type (2017-2027)
Table 49. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Pemetrexed in US (2017-2021)
Table 53. Market Price (USD/Unit) for Each Type of Pemetrexed in Europe (2017-2021)
Table 54. Market Price (USD/Unit) for Each Type of Pemetrexed in China (2017-2021)
Table 55. Market Price (USD/Unit) for Each Type of Pemetrexed in Japan (2017-2021)
Table 56. Market Price (USD/Unit) for Each Type of Pemetrexed in India (2017-2021)
Table 57. Market Price (USD/Unit) for Each Type of Pemetrexed in Korea (2017-2021)
Table 58. Market Price (USD/Unit) for Each Type of Pemetrexed in Southeast Asia (2017-2021)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Eli Lilly Profiles
Table 61. Eli Lilly Pemetrexed Product Introduction
Table 62. Eli Lilly Pemetrexed Sales (Unit), Revenue (Million USD) (2017-2021)
Table 63. Eli Lilly Strategic initiatives
Table 64. Abbott Healthcare Profiles
Table 65. Abbott Healthcare Pemetrexed Product Introduction
Table 66. Abbott Healthcare Pemetrexed Sales (Unit), Revenue (Million USD) (2017-2021)
Table 67. Abbott Healthcare Strategic initiatives
Table 68. Cadila Healthcare Profiles
Table 69. Cadila Healthcare Pemetrexed Product Introduction
Table 70. Cadila Healthcare Pemetrexed Sales (Unit), Revenue (Million USD) (2017-2021)
Table 71. Cadila Healthcare Strategic initiatives
Table 72. ... Profiles
Table 73. ... Pemetrexed Product Introduction
Table 74. ... Pemetrexed Sales (Unit), Revenue (Million USD) (2017-2021)